Media

Event
Medical
Corporate
Medical
2020-09-16

Genomic sequencing helps the combination of two immune checkpoint inhibitors to control stage IV nasopharyngeal carcinoma

A cancer patient is identified by comprehensive genomic profiling as TMB-H with better response to immunotherapy and the combination of two immune checkpoint inhibitors is used to control stage IV nasopharyngeal carcinoma successfully

Published:

Taipei

Author(s):

HealthNews

Corporate
2020-09-08

Genomics in Business Opportunities — A big difference in Eastern & Western melanoma patients

Immunotherapy shows better efficacy in Western melanoma patients than Asian patients. ACT Genomics cooperates with medical institutes to understand the molecular information of melanoma for better treatment.

Published:

Hong Kong

Author(s):

Dr. Hua -Chien Chen

Corporate
2020-08-24

Business Opportunities in Genomics-NGS can help evaluating immunotherapy

Via Next Generation Sequencing, TMB-H cancer patients have positive progress after using immunotherapy

Published:

Hong Kong

Author(s):

Dr. Hua-Chien Chen

Corporate
2020-08-20

Business Opportunities in Genomics-Using genomic profiling to find suitable targeted drugs

Through ideal medical perspective, genomic profiling can also enable patients to maintain normal life and quality beside providing suitable medical solutions.

Published:

Hong Kong

Author(s):

Dr. Hua-Chien Chen

Corporate
2020-08-20

Business Opportunities in Genomics-New targeted drugs for lung cancers

NGS can help cancer patients treat cancer with the right drugs, and through more targeted drugs, it will be easier to treat lung cancer.

Published:

Hong Kong

Author(s):

Dr. Hua-Chien Chen

Medical
2020-08-03

The special disease progress of a 62-year-old lung cancer patient is controlled after performing genomic profiling sequencing twice

The treatment options for late-stage lung cancer treatment are limited and NGS can overcome brain metastases mostly seen in late-stage.

Published:

Taipei

Author(s):

Healthnews

Medical
2020-07-27

Genomic profiling can find right drug for late-stage ovarian cancer patients

Cancer genomic profiling is the key to prevent recurrence of late-stage ovarian cancer. Sequencing 48 DNA repair genes at once can find right targeted drugs to extend the PFS of ovarian cancer patients.

Published:

Taipei

Author(s):

Healthnews

Corporate
2020-07-13

Business Opportunities in Genomics- Provide subsidy in cancer genomics profiling service

Since 2020 July, ACT Genomics and pharmaceutical care foundation cooperate on the yearly program to subsidize cancer genomic profiling for patients to find drugs. Please visit-> http://www.pcfhk.org/hk/pharmacy?id=30

Published:

Hong Kong

Author(s):

Dr. Hua-Chien Chen

Corporate
2020-06-29

Business Opportunities in Genomics- The public & private development of genomics

The Food and Health Bureau of the Government of the Hong Kong Special Administrative Region and universities provide solid foundation for genomic profiling, while private company can accelerate market maturity and provide solutions in short terms.

Published:

Hong Kong

Author(s):

Dr. Hua-Chien Chen

Corporate
2020-06-19

Decode Melanoma In Asian Patients Through Collaboration Among ACT Genomics, KMU and NHRI

To treat Melanoma, immunotherapy shows only half effect in Asian patients comparing to Western patients. ACT Genomics is working with KMU and NHRI to find better treatment for Asians.

Published:

Taipei

Author(s):

CNA